FDA Approved Medical Products for:

Paroxysmal nocturnal hemoglobinuria

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Eculizumab
Trade Name
(Manufacturer Name)
Soliris®
(Alexion Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of paroxysmal nocturnal hemoglobinuria to reduce hemolysis
More Information about this product Drug Information Portal